Second, treatment with recombinant IL2 may be associated with severe adverse effects, including capillary leak syndrome (vascular leak syndrome); severe infection, systemic inflammatory response syndrome, or pyrexia (fever); and cardiovascular, gastrointestinal (GI), hematologic, neurologic, hepatic, or urogenital adverse events (AE). This evidence concerns the gene IL2 and Fever.